We are live on ! Find out more
GF

Gray Foundation Portfolio holdings

AUM $454M
1-Year Est. Return 38.19%
This Fund
S&P 500
This Quarter Est. Return
+0.13%
1 Year Est. Return
+38.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$397M
AUM Growth
-$1.78M
Cap. Flow
-$193
Cap. Flow %
-0%
Top 10 Hldgs %
99.09%
Holding
11
New
–
Increased
–
Reduced
1
Closed
–
Avg Time Held
6.8 quarters
Top 10 Avg Time Held
7.4 quarters
Top 20 Avg Time Held
6.8 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$193

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 58.17%
2 Miscellaneous 28.11%
3 Communication Services 8.1%
4 Healthcare 2.16%
5 Real Estate 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HLT icon
1
Hilton Worldwide
HLT
$71.4B
$222M 56.08%
731,666
– –
2023 Q4
9 quarters
IGM icon
2
iShares Expanded Tech Sector ETF
IGM
$11.7B
$66.3M 16.7%
559,116
– –
2023 Q4
9 quarters
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.17T
$32.1M 8.1%
112,000
– –
2023 Q4
9 quarters
INDA icon
4
iShares MSCI India ETF
INDA
$5.78B
$19.9M 5.03%
425,748
– –
2023 Q4
9 quarters
ROBO icon
5
ROBO Global Robotics & Automation Index ETF
ROBO
$2.08B
$14M 3.54%
205,000
– –
2023 Q4
9 quarters
SOXX icon
6
iShares Semiconductor ETF
SOXX
$49.2B
$11.3M 2.85%
34,371
– –
2023 Q4
9 quarters
INVH icon
7
Invitation Homes
INVH
$15.4B
$8.47M 2.13%
340,734
– –
2023 Q4
9 quarters
HGV icon
8
Hilton Grand Vacations
HGV
$2.68B
$8.31M 2.1%
212,520
– –
2023 Q4
9 quarters
BA icon
9
Boeing
BA
$152B
$5.25M 1.32%
26,400
– –
2025 Q4
1 quarter
NBIX icon
10
Neurocrine Biosciences
NBIX
$14.6B
$4.98M 1.26%
37,800
– –
2025 Q4
1 quarter
AZN icon
11
AstraZeneca
AZN
$242B
$3.6M 0.91%
18,268
-1
-0% -$193
2025 Q4
1 quarter

Similar funds

Gray Foundation's Q1 2026 Portfolio in Review

As of Q1 2026, Gray Foundation held 11 positions worth $397M, down 0.45% from $399M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 0%. Gray Foundation opened no new positions and made no exits, leaving the 11-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 58% of assets, up from 55% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Gray Foundation's biggest Q1 2026 reduction was AstraZeneca, cutting an estimated $193.
  • Gray Foundation's ten largest holdings make up 99% of its $397M portfolio in Q1 2026.
  • Gray Foundation opened 0 new positions and closed 0 in Q1 2026.
  • Gray Foundation's portfolio value fell 0.45% quarter-over-quarter to $397M.

Based on Gray Foundation's 13F filing for Q1 2026, filed 22 Apr 2026.